Company Information

  

Address: 1098 FOSTER CITY BLVD.
SUITE 106-810 
City: FOSTER CITY 
State: CA 
Zip Code: 94404 
Telephone: 646-367-1747 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Aoxing Pharmaceutical Company, Inc. ("Aoxing Pharma" or "Company") has one operating subsidiary, Hebei Aoxing Pharmaceutical Co., Inc. ("Hebei Aoxing"), which is organized under the laws of the People's Republic of China ("PRC"). Since 2002, Hebei Aoxing has been engaged in developing narcotics and pain management products. In 2008 Hebei Aoxing supplemented its product lines by acquiring Shijiazhuang Lerentang Pharmaceutical Company, Ltd. ("LRT"), a specialty pharmaceutical company focusing on herbal pain related therapeutics. The Company owns 95% of the equity in Hebei Aoxing. History of the Company The Company was incorporated in the State of Florida on January 23, 1996. In 2006 the Company liquidated its previous business assets and acquired 60% of Hebei Aoxing. On May 1, 2008 the Company completed the acquisition of an additional 35% interest in Hebei Aoxing from Zhenjiang Yue, our Chief Executive Officer.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2017-0.01NAN/E
12/2016-0.02NAN/E
09/20160.01NA55.79
06/20160.03NA21.67
03/20160.12NA5.50
12/20150.13NA5.14
09/20150.11NA13.45
06/20150.09NA19.44

Key Financial Ratios and Statistics

FYE: 06/30

Profitability 2016 Leverage 2016
Net Inc/Comm Equity0.03Total Liab/Total Assets0.68
Net Inc/Total Assets0.04Total Liab/Inv Cap-5.41
Net Inc/Inv Cap-0.29Total Liab/Comm Equity0.52
Pretax Inc/Net Sales0.09Interest Coverage Ratio1.83
Net Inc/Net Sales0.06Curr Debt/Equity1.33
Cash Flow/Net Sales-0.02LTD/EquityNA
SG&A/NetSales0.45Total Debt/Equity1.33
Asset Utilization   Liquidity  
Net Receivables Turnover3.79Quick Ratio0.64
Inventory Turnover2.56Current Ratio0.71
Inventory Day Sales0.01Net Rec/Curr Assets0.42
Net Sales/Work Cap-2.95Inv/Curr Assets0.11
Net Sales/PP&E1.26  

Income Statement (Millions)

  3/31/2017 12/31/2016 9/30/2016 6/30/2016
Total Revenues(Net Sales) 5.70 8.01 7.57 8.82
Cost of Goods Sold 1.28 1.71 1.51 2.66
Selling & Admin Exps 3.35 5.87 3.85 5.92
Operating Income 0.88 0.23 1.70 -1.85
Interest Exp 0.65 0.64 0.66 0.95
Pretax Income 0.30 -0.39 1.04 -2.82
Other Income 0.07 0.02 0.00 -0.00
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 0.13 -0.04 0.35 -1.90

Balance Sheet (Millions)

Assets 3/31/2017 12/31/2016 9/30/2016 6/30/2016
Cash & Short Term Investments 7.08 6.85 7.06 6.91
Receivables - Total 15.29 13.64 13.99 11.20
Inventories - Total 2.41 2.04 2.43 2.84
Total Current Assets 34.80 30.84 30.10 26.87
Net Property, Plant & Equipment 24.04 24.07 25.28 25.60
Total Assets 62.47 58.72 58.77 56.23
Liabilities        
Accounts Payable 16.35 16.22 14.54 12.34
Debt in Current Liabilities 27.62 24.29 25.30 25.47
Total Current Liabilities 43.97 40.51 39.84 37.82
Long-Term Debt 0.10 0.10 0.10 0.00
Total Liabilities 44.38 40.92 40.26 38.16
Stockholder's Equity        
Minority Interest -1.02 -1.04 -1.02 -1.06
Preferred Stock NA NA NA NA
Common Stock 0.08 0.08 0.08 0.08
Retained Earnings -55.86 -55.99 -55.95 -56.29
Treasury Stock NA NA NA NA
Total Stockholders' Equity 19.11 18.84 19.53 19.14
Total Liabilities and Stockholders' Equity 63.49 59.76 59.79 57.29

Cash Flow Summary (Millions)

Categories 3/31/2017 12/31/2016 9/30/2016 6/30/2016
Net Cash Provided by Operating Activities -3.02 0.09 0.13 1.43
Net Cash Provided by Investing Activities -0.00 -0.01 -0.00 -0.02
Net Cash Provided by Financing Activities 3.18 0.00 0.00 -0.32

Annual Summary Data (Millions)

Year Sales Net Income EPS
06/20128.13-15.82-0.32
06/201310.83-16.80-0.34
06/201412.74-8.22-0.16
06/201525.485.490.09
06/201632.332.060.03
Growth Rates41.20----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17112470.32




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.